NCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
Clinical Trials
5 trialsNCT05085561 2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2 Completed
NCT06214767 2025-07-30
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Beijing Tiantan Hospital
Recruiting
NCT07026604 2025-06-18
CCM-DS01
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT01764529 2025-05-29
Modifiers of Disease Severity in Cerebral Cavernous Malformations
University of California, San Francisco
Active not recruiting